#CPHI22: Supply chain woes are still bearing down on manufacturers
It’s no secret that the wider events in the global landscape, such as the lingering effects of Covid-19 as well as the ongoing conflict in Ukraine and inflation costs, have made manufacturers feel the pinch this year. These elements have created challenges for manufacturers and managing supply chains.
Looking deeper into the supply chain issues, Aurelio Arias, the engagement manager for thought leadership at IQVIA, said in an email to Endpoints News that now rising energy costs are the latest supply issue to hit. This was brought up by Elisabeth Stampa, president of Medicines for Europe, a group that represents the generic industry on the continent. Stampa had sent a letter addressed to energy ministers and commissioners concerning inflation and the costs of energy on the supply of generic medicines.
Keep reading Endpoints with a free subscription
Unlock this story instantly and join 163,800+ biopharma pros reading Endpoints daily — and it's free.